Web(NASDAQ: CSTL) Castle Biosciences's current Earnings Per Share (EPS) is -$2.58. On average, analysts forecast that CSTL's EPS will be -$3.08 for 2024, with the lowest EPS forecast at -$3.35, and the highest EPS forecast at -$2.58. In 2024, CSTL's EPS is forecast to hit -$2.17 (min: -$2.60, max: -$1.74). Web1 hour ago · J.P. Morgan analyst David Low maintained a Buy rating on CSL (CMXHF – Research Report) on April 12 and set a price target of A$358.00. The company’s shares closed yesterday at $203.97. The ...
CSTL: Castle Biosciences - Price & Consenus Chart - Zacks.com
WebCastle Biosciences, Inc. Common Stock (CSTL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Web2 days ago · Back on 16 April 1999, CSL closed the day trading for $4.23 per share. That means I could have bought 236 shares with my $1,000 and had enough left over for a … open bank account for sole proprietor
Why did the CSL share price lag the ASX 200 in the first quarter of …
WebStock Price Buy; CSL0902VT1C DISTI # C1S625902146135. ROHM Semiconductor High brightness Lens Type, Red Chip Led RoHS: Compliant pbFree: No Min Qty: 5 Container: … WebApr 12, 2024 · Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the 22nd Annual Needham Virtual Healthcare … WebApr 10, 2024 · Castle Biosciences, Inc. (CSTL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ... open bank account for offshore company